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The remarkable regenerative capacity of the zebraﬁsh has made it an important model organism for
studying heart regeneration. However, current loss-of-function studies are limited by a lack of condi-
tional-knockout and effective gene-knockdown methods for the adult heart. Here, we report a novel
siRNA knockdown method facilitated by poly(ethylene glycol)-b-poly(D,L-lactide) (PEG–PLA) nano-
particles. The siRNA-encapsulated nanoparticles successfully entered cells and resulted in remarkable
gene-speciﬁc knockdown in the adult heart. This effect was demonstrated by down-regulation of the
Aldh1a2 and Dusp6 proteins after intrapleural delivery of nanoparticle-encapsulated siRNAs. Further-
more, siRNA-mediated knockdown of Aldh1a2 was sufﬁcient to inhibit myocardial proliferation and
decrease the numbers of Gata4-positive cardiomyocytes after ventricular resection. Therefore, the results
of this work demonstrate that nanoparticle-facilitated siRNA delivery provides an alternative tool for
loss-of-function studies of genes in the adult heart in particular and other organs in general in the adult
zebraﬁsh.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
Heart disease has become a major devastating health issue,
leading to salient mortality and a tremendous economic burden
around the world (Go et al., 2014). Mammals, including human
beings, have a very limited capacity to repair the heart after
myocardial infarction. Instead of producing new cardiomyocytes,
the injury is normally replaced by non-contractile scar tissues, and
this often leads to heart failure. In contrast, the adult zebraﬁsh
regenerates its heart perfectly after ventricular resection, cryoin-
jury, or genetic depletion of cardiomyocytes, making it an ideal
model organism for investigating the molecular mechanisms un-
derlying heart regeneration (Chablais et al., 2011; Gonzalez-Rosa
et al., 2011; Parente et al., 2013; Poss et al., 2002; Raya et al., 2003;
Schnabel et al., 2011; Wang et al., 2011). However, a lack of con-
ditional-knockout and effective gene-knockdown methods for
adult organs remains a bottleneck for mechanistic studies in
zebraﬁsh. Currently, pharmacological inhibitors and the transgenic
expression of dominant-negative mutants are primarily used tone, Peking University, Beijing
Xiong).investigate gene function during regeneration of the adult zebra-
ﬁsh heart (Han et al., 2014; Jopling et al., 2010; Lepilina et al.,
2006). However, not all genes or signal pathways have dominant-
negative mutants or pharmacological inhibitors; and the zebraﬁsh
heat-shock promoter, which is used to drive transgene expression,
is frequently silenced in the adult zebraﬁsh heart (unpublished
observations). Therefore, an efﬁcient gene-knockdown in the adult
heart in particular, and other organs in general, is urgently needed.
Since the discovery of RNA interference in 1998, small-inter-
fering RNAs (siRNAs) have been widely used for loss-of-function
analysis in mammalian cells and model organisms (McManus and
Sharp, 2002), as well as for treating numerous diseases in animal
models (de Fougerolles et al., 2007; Kim and Rossi, 2007; McCaf-
frey et al., 2003; Raoul et al., 2005). Among these applications,
siRNAs are capable of effectively silencing target genes in tumors
(Hu-Lieskovan et al., 2005; Schiffelers et al., 2004; Yang et al.,
2011) and in mammalian cardiomyocytes (Ko et al., 2009; Liu et al.,
2013; Nam et al., 2012, 2010; Won et al., 2013) with the assistance
of different delivery systems. Based on our previous work in
mammalian cells (Yang et al., 2011), we report here on developing
effective siRNA-knockdown of genes in the adult zebraﬁsh heart,
aided by cationic lipid-assisted poly(ethylene glycol)-b-poly(D,L-
lactide) (PEG–PLA) nanoparticles.
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2.1. Preparation of PEG–PLA nanoparticle-encapsulated siRNA
PEG–PLA nanoparticles loaded with siRNA were prepared using
a double emulsion-solvent evaporation technique as previously
described (Yang et al., 2011). Brieﬂy, 0.2 mg siRNA in 25 μL RNase-
free water was ﬁrst emulsiﬁed by sonication for 60 s over an ice
bath in 0.5 ml chloroform containing 1.0 mg BHEM-Chol and
25 mg PEG5k–PLA11k. This primary emulsion was further emulsi-
ﬁed by sonication (80 W for 1 min) in 5 mL RNase-free water over
an ice bath to form a water-in-oil-in-water emulsion. The mixture
was then added to a 50-mL round-bottom ﬂask, and the solvent
(chloroform and RNase-free water) was concentrated under re-
duced pressure by a rotary evaporator to a volume of 1 mL. The
siRNA encapsulation efﬁciency, zeta potential, and particle size
measurements were conducted according to a high-performance
liquid chromatography procedure or using a Malvern Zetasizer
Nano ZS90, as previously reported (Yang et al., 2011).
The ﬂuorescence-labeled cy5-siRNAs were: negative control
siRNA with a scrambled sequence (antisense strand, 5′-ACGUGA-
CACGUUCGGAGAAdTdT-3′), siRNA targeting Aldh1a2 mRNA
(siAldh1a2, antisense strand, 5′-UUCAGGACAACCGUGUUCCTT-3′,
siAldh1a2-2, antisense strand, 5′-UUUGUCUAUGCCCAUGUGCTT-
3′) and siRNA targeting Dusp6 mRNA (siDusp6, antisense strand,
5′-AACUGCUGCUUGACGAACCTT-3′, siDusp6-2, antisense strand,
5′-AUCCAGGUUUGUGGAGUCCTT′). These siRNAs were synthe-
sized by Shanghai Jima Life Science Co. (Shanghai, China).
2.2. Zebraﬁsh husbandry
Zebraﬁsh were raised and handled according to protocols ap-
proved by the Peking University Animal Care and Use Committee
in a facility that is fully accredited by the AAALAC. Wild-type TL
and Tg (gata4: EGFP) transgenic zebraﬁsh lines at 6–12 months of
age were used for heart surgery. The Tg (gata4: EGFP) transgenic
zebraﬁsh were generously provided by Dr. Todd Evans (Cornell
University Medical Center, New York, NY) (Heicklen-Klein and
Evans, 2004). Tg(ﬂk1: EGFP) ﬁsh was provided by Dr. Feng Liu
(Institute of Zoology, Chinese Academy of Sciences, Beijing, China).
Tg(myl7:EGFP) and Tg(tcf21:DsRed) zebraﬁsh lines were from Dr.
Geoffrey Burns (Massachusetts General Hospital, Charlestown,
MA) (Burns et al., 2005; Kikuchi et al., 2011).
2.3. Adult zebraﬁsh heart resection
Ventricular resection was carried out mainly as previously de-
scribed (Han et al., 2014; Poss et al., 2002). Brieﬂy, after anesthesia
in tricaine, the zebraﬁsh was placed supinely into the groove of a
sponge. The pericardial sac was exposed by removing the surface
scales and a small piece of skin using iridectomy scissors. The
pericardial sac was opened with the aid of tweezers, and the apex
of the ventricle was gently pulled up and cut with Vannas scissors.
Immediately after ventricular resection, a small piece of wet paper
tissues was placed on the ventricular wound. The bleeding ceased
very quickly (within 10–15 s) due to the formation of blood clots.
The ﬁsh was put back into a water tank, and water was puffed over
the gills with a plastic pipette until it breathed and swam nor-
mally. The surface wound sealed within a few days.
2.4. BrdU incorporation and siRNA treatments
After ventricular resection, zebraﬁsh were allowed to recover
for 1 day. Fifty microliters of 2.5 mg/ml BrdU (B5002; Sigma; St.
Louis, MO) was then co-injected with 5 μM nanoparticle-en-
capsulated siRNA (CY5-labeled, siAldh1a2, or siDusp6 siRNA), or5 μM naked siRNA (CY5-labeled, siAldh1a2, or siDusp6 siRNA), or
scrambled negative control. siRNAs was microinjected into the
thoracic cavity once daily until the hearts were collected. For
Supplemental Fig. S6E–J, BrdU was injected once a day from 10 to
14 dpa. For Supplemental Fig. S7, ﬁve microliters of 5 μM nano-
particle-encapsulated siAldh1a2 (siAldh1a2), or 5 μM negative
control siRNA with a scrambled sequence (siN.C.) were injected
from 1 to 9 dpa; and ﬁve microliters of siAldh1a2 or siN.C. and
2.5 mg/ml BrdU (B5002; Sigma; St Louis, MO) were then co-in-
jected into the thoracic cavity from 10 to 14 dpa. To optimize the
injection volume, we injected 5, 10, or 20 μl of 0.5% phenol red
(P0290; Sigma) into the thoracic cavity and then monitored the
leakiness, noting that 10 μl is the maximal volume for the thoracic
cavity in zebraﬁsh.
2.5. Western blotting
Zebraﬁsh hearts were homogenized in cell lysis buffer (P0013;
Beyotime, Beijing, China) with the addition of a protease inhibitor
cocktail (P8340; Sigma) and PhosStop phosphatase inhibitor
cocktail (04906845001; Roche). Proteins were quantiﬁed with a
BCA kit (PA115; Tiangen Biotech, Beijing, China), resolved on 10%
SDS-PAGE gels, and transferred onto PVDF membranes (162-0177;
Bio-rad). The membranes were then incubated with primary an-
tibody and then with the corresponding HRP-conjugated second-
ary antibody. Proteins were detected with ECL western blotting
substrates (W1001; Promega).
2.6. Immunostaining and histology
Adult hearts were immersed in 4% paraformaldehyde at room
temperature for 2 h, and parafﬁn embedding and sectioning
(4 μm) were performed followed by dehydration in a series of
ethanols. The primary antibodies were anti-BrdU (B8434; Sigma),
anti-Mef2C (sc-313; Santa Cruz), anti-GFP (A-11122; Invitrogen),
anti-GAPDH (sc-166545; Santa Cruz), MF20 (Developmental Stu-
dies Hybridoma Bank), anti-Dusp6 (WH0001848M1; Sigma), anti-
β-actin (4967; Cell Signaling) and anti-Aldh1a2 (P30011; Abmart).
The secondary antibodies used for immunostaining were Alexa
Fluor 488 goat anti-mouse IgG (A21121; Invitrogen), Alexa Fluor
488 goat anti-rabbit IgG (A11034; Invitrogen), Alexa Fluor 555 goat
anti-mouse IgG (A21424; Invitrogen), and Alexa Fluor 555 goat
anti-rabbit IgG (A21428; Invitrogen). The secondary antibodies for
western blotting were HRP goat anti-rabbit IgG (sc-2004; Santa
Cruz) and HRP goat anti-mouse IgG (sc-2005; Santa Cruz).
2.7. Cryosections and confocal imaging
SiRNA-coupled nanoparticles were injected intrapleurally at
2.5 mg/kg of body weight. After the hearts were removed from
anesthetized ﬁsh at given time-points, they were immediately
immersed in phosphate buffer solution (PBS) and examined under
an in vivo imaging system (Kodak In-Vivo Imaging System FX Pro,
Carestream Health, USA) to detect the CY5 ﬂuorescence signal. The
tissues were then placed in the tissue cassettes, embedded in OCT,
and frozen on a piece of foam ﬂoating on liquid nitrogen until the
OCT solidiﬁed. The samples were then cut into 6-μm sections and
collected on glass slides. DAPI was used to label the nuclei and the
cryosections were examined under a confocal microscope (Zeiss
510; Zeiss, Germany).
2.8. Statistical analysis
Data are expressed as the mean7SEM. Statistical comparisons
were carried out using two-tailed Student's t-test analysis of var-
iance. For Supplemental Fig. S6K, statistic signiﬁcance between
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considered to be statistically signiﬁcant.3. Results and discussion
Our previous studies have demonstrated the utility of PEG–PLA
nanoparticles for the systemic delivery of siRNAs in cancer therapy
(Liu et al., 2013; Yang et al., 2011). Here, we redesigned this
methodology for siRNA delivery to the adult zebraﬁsh heart after
ventricular resection (Fig. 1). As described previously (Yang et al.,
2011), the structures of PEG–PLA and BHEM-Chol, as well as the
preparation of siRNA-loaded particles are illustrated (Fig. 1A). The
encapsulation efﬁciency of siRNA was 50% in the formulation, in
which the weights of siRNA, BHEM-Chol, and PEG5K–PLA25K were
0.2 mg, 1.0 mg and 25 mg, respectively. The diameter of the siRNA-
loaded particles was 125 nmwith the minimally-required ratios,
which were determined using a zeta-potential analyzer with dy-
namic light-scattering. The corresponding zeta-potential of these
particles was 23 mV. The siRNA-loaded particles were prepared
one day after ventricular resection. Six-month-old wild-type TL
zebraﬁsh were subjected to ventricular resection, and siRNA par-
ticles with or without BrdU were then co-injected intrapleurally
once daily until the hearts were harvested for whole-heart ima-
ging, western blotting, and/or immunostaining (Fig. 1B).
To determine the efﬁciency of delivery of PEG–PLA nano-
particle-encapsulated siRNA, we intrapleurally injected CY5-la-
beled siRNA and measured the ﬂuorescence signal in injuredFig. 1. Overview of preparation and delivery of nanoparticle-encapsulated siRNAs into z
siRNA facilitated by cationic lipids (BHEM-Chol) and PEG–PLA using a double-emulsion
6-month old (6 m) were subjected to ventricular resection; (2) microinjection of encap
examination of CY5-labeled siRNA entering cardiac cells using an imaging system and con
gene knockdown; and (5) functional analysis of the effects of siRNA knockdown on hear
cardiomyocytes.zebraﬁsh hearts. After ventricular resection, we detected a CY5-
siRNA ﬂuorescence signal 3 h post injection (hpi), which was
barely attenuated at 24 h, while there was no detectable ﬂuores-
cence signal in either water-injected (mock) or naked siRNA-in-
jected hearts (Fig. 2A; Supplemental Fig. S1B). Cumulative, steady
signals in the heart at 24 h after siRNA administration suggested
that nanoparticle-encapsulated siRNA was gradually released
(Fig. 2A and B). The ﬂuorescent signals then declined from 1 to
3 dpi (Supplemental Fig. S1C). In addition, we found that CY5-
siRNA was also accumulated in isolated intestine and liver but less
in isolated kidney and spleen (Supplemental Fig. S1A). To verify
this conclusion from in vivo whole-heart imaging, we determined
the subcellular localization of CY5-siRNA after nanoparticle-
mediated delivery using laser-scanning confocal microscopy. Na-
noparticle-encapsulated CY5-labeled siRNA was injected 1 day
after ventricular resection, and cryosections of the injured hearts
were then prepared for immunostaining at the indicated time
points (Fig. 2C–H; Supplemental Fig. S2A–C). CY5-siRNAwas found
primarily in the cytoplasm and not in the DAPI-labeled nuclei,
which is consistent with our previous ﬁnding that PEG–PLA na-
noparticle-encapsulated siRNA is localized in lysosomes in mam-
malian cells (Yang et al., 2011). Encapsulated siRNA entered all
three types of cells in the heart we examined, including Tg(myl7:
EGFP)-labeled cardiomyocytes, Tg(ﬂk1:EGFP)-labeled en-
docardium, and Tg(tcf21:DsRed)-labeled epicardium (Supple-
mental Fig. S2), suggesting no preference in entering a particular
cell type by this nanoparticle-mediated siRNA delivery. Similar to
in vivo whole-heart imaging data, we found a strong ﬂuorescenceebraﬁsh hearts after ventricular resection. (A) Schematic of preparing encapsulated
method (Yang et al., 2011). (B) Experimental design: (1) wild-type TL zebraﬁsh at
sulated CY5-labeled siRNA into the heart after ventricular resection at 1 dpa; (3)
focal microscopy; (4) western blot and immunostaining to conﬁrm siRNA-mediated
t regeneration, using BrdUþ/Mef2cþ proliferating cardiomyocytes and Gata4-EGFP
Fig. 2. Effective nanoparticle-assisted delivery of siRNA into the adult zebraﬁsh heart. (A) Fluorescence images of CY5-siRNA accumulation in isolated zebraﬁsh heart under
the in vivo imaging system. Note that ﬂuorescence signals were hardly detectable in the negative control (Mock) and unencapsulated siRNA (Naked) groups at 24 hpi, and
were increased in the nanoparticle-encapsulated siRNA groups from 3 to 24 hpi. An arbitrary scale of ﬂuorescence signal is shown from blue (low) to red (high).
(B) Quantiﬁcation of CY5-siRNA in heart tissues using the in vivo imaging system (*Po0.05). (C–G) Fluorescent images of cryosections of heart tissues under confocal
microscopy. Note the clear CY5-siRNA signal in the experimental group at 3, 6 and 24 hpi but very little signal in the negative control (Mock) and naked siRNAs (Naked)
groups at 24 hpi. Enlarged siRNA localization is shown (E–G, low-right corner). DAPI was used to stain nuclei. Scale bar, 50 μm. (H) Quantiﬁcation of the CY5-siRNA
ﬂuorescence signals in Fig. 2C–G. (*Po0.05).
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(Fig. 2E–H) while there was no detectable ﬂuorescence signal in
either water-injected (mock) or naked siRNA-injected hearts
(Fig. 2C, D and H). Taken together, these data suggested that PEG–
PLA nanoparticles effectively facilitated the delivery of siRNAs into
the adult zebraﬁsh heart after injury.
We then asked whether the PEG–PLA nanoparticle-en-
capsulated siRNA efﬁciently causes gene-speciﬁc knockdown. We
targeted two known genes, Aldh1a2 (retinoic acid (RA)-synthe-
sizing enzyme) and dusp6 (also known as MAP-kinase phospha-
tase, mkp3), both of which are up-regulated during zebraﬁsh heart
regeneration (Han et al., 2014; Kikuchi et al., 2011). Im-
munostaining showed that siAldh1a2 inhibited Aldh1a2 expres-
sion (Fig. 3B and B′) compared with the negative control siRNA
(siN.C.) group (Fig. 3A and A′) at 2 days post amputation (dpa).
Western blotting provides further evidence that siAldh1a2inhibited Aldh1a2 but neither the negative control nor naked
siAldh1a2 had any effect on Aldh1a2 expression at 2 dpa (Fig. 3C
and D). Importantly, the injury-induced expression of Aldh1a2 in
siAldh1a2-treated hearts was reduced to a level comparable to
that in sham hearts, suggesting that nanoparticle-mediated
siAldh1a2-knockdown is highly efﬁcient. Similarly, both im-
munostaining and western blotting showed that siDusp6 also
speciﬁcally suppressed Dusp6 expression compared with that in
the negative control and naked siDusp6 groups (Fig. 3E–H). The
siDusp6 attenuated the induction of Dusp6 after ventricular re-
section to the similar level as that in sham hearts, further sub-
stantiating the efﬁciency of knockdown. Furthermore, the si-
Dusp6-mediated knockdown led to increased pErk in injured heart
at 2 day post-injection of encapsulated siRNAs (Supplemental Fig.
S2). Statistic analysis showed that the siRNA-silencing efﬁcacy
reached 450% for both genes (Fig. 3D and H). Second siRNAs,
Fig. 3. Efﬁcient siRNA knockdown of aldh1a2 and dusp6 in the adult zebraﬁsh heart. (A, B) Immunostaining showed Aldh1a2 expression in the epicardium and endocardium
of negative control (siN.C.)-injected hearts (A, A′) and siAldh1a2 siRNA-injected hearts (B, B′). MF20 staining marks the myocardium. (C, D) Western blots showing that
nanoparticle-encapsulated siAldh1a2 reduced Aldh1a2 expression to a level comparable to that in the sham group, compared to the nanoparticle-encapsulated siN.C. and
naked siAldh1a2 groups at 2 dpa (C), and quantitative knockdown of Aldh1a2 (D). (E, F) Immunostaining showed Dusp6 expression in the epicardium of siN.C.-injected
control hearts (E, E’) and siDusp6-injected hearts (F, F′). Mef2C staining marks the myocardium. (G, H) Western blots showing that nanoparticle-encapsulated siDusp6
reduced Dusp6 expression to a level comparable to that in the sham group, compared with the nanoparticle-encapsulated siN.C. and naked siDusp6 groups at 2 dpa (G), and
quantitative knockdown of Dusp6 (H). Scale bars, 100 μm.
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found to have gene-speciﬁc knockdown for Aldh1a2 and Dusp6
similar to those with siAldh1a2 and siDusp6 by immunostaining
and western blots (Supplemental Fig. S3). Furthermore, en-
capsulated siAldh1a2-2 inhibited the Mef2Cþ/BrdUþ proliferating
cardiomyocytes while it had no effect on cell apoptosis in the heart
(Supplemental Fig. S4). In addition, daily injection of scrambled
siRNA (siN.C.) had no apparent effect on cardiac ﬁbrosis at 30 dpa
(Supplemental Fig. S6A–D). To minimize the injection volume, we
found the thoracic cavity could hold the maximal amount of 10 μl
phenol red in zebraﬁsh (Supplemental Fig. S7A–C), suggesting that
the majority of injected volume leaked out when we injected 50 μl
siRNA. Indeed, we found that 5 μl siAldh1a2 knockdown had si-
milar effect on Mef2Cþ/BrdUþ proliferating cardiomyocytes as 50
μl siAldh1a2 injections (Supplemental Fig. S7; Fig. 4C, D and F).
Taken together, just as in mammalian cells (Yang et al., 2011), PEG–
PLA nanoparticle-mediated siRNAs achieved speciﬁc knockdown
of their target genes, aldh1a2 and dusp6, in the adult heart.
We further asked whether siRNA-mediated knockdown of
aldh1a2 had functional consequences during zebraﬁsh heart re-
generation. Poss and colleagues have shown that aldh1a2 is acti-
vated in the endocardium and epicardium and RA signaling is
essential for myocardial proliferation during zebraﬁsh heartregeneration (Kikuchi et al., 2011). To determine whether the re-
duced Aldh1a2 protein levels caused by nanoparticle-mediated
siRNA knockdown were sufﬁcient to interfere with RA synthesis/
signaling, we intrapleurally injected encapsulated siAldh1a2 once
a day after ventricular amputation and collected the hearts at
14 dpa for analyses. Gata4-GFP myocytes have been shown to be
actively involved in myocardial regeneration in zebraﬁsh (Han
et al., 2014; Kikuchi et al., 2011). We found that Gata4-GFP myo-
cytes signiﬁcantly decreased in the siAldh1a2-treated group
compared with that in the negative control group (Fig. 4A, B and
E), suggesting that the RA signaling was compromised by siAld-
h1a2 treatment. Furthermore, siAldh1a2 reduced the cardiomyo-
cyte proliferation index (8%) after 14-day of siAldh1a2 adminis-
tration compared with that (15%) in the negative control group
(Fig. 4C, C′, C″, C‴, D, D′, D″, D‴, and F). Together, our data support
the conclusion that the PEG–PLA nanoparticle-encapsulated siRNA
efﬁciently decreased the targeted Aldh1a2 protein levels and led to
functional disruption of RA signaling during heart regeneration.
Brieﬂy, we have developed a new loss-of-function method for
silencing speciﬁc genes during regeneration in the adult zebraﬁsh
heart, using a PEG–PLA copolymer along with an amphiphilic and
cationic lipid. This siRNA-delivery system efﬁciently transferred
siRNA into the heart tissue and escaped from endosomes, and in
Fig. 4. Nanoparticle-aided suppression of Aldh1a2 impedes cardiac regeneration. (A, B) siAldh1a2 inhibited Gata4-GFP cardiomyocytes in the injured areas (B, B′) compared
with negative (siN.C.) control treatment (A, A′). MF20 marks the myocardium. (C, D) siAldh1a2 diminished the numbers of BrdUþ/Mef2Cþ proliferating myocytes (D, D′)
compared with siN.C. treatment (C, C′) at 14 dpa. (E) Statistics of Gata4-GFP cardiomyocytes from A, B. (F) Statistics of Mef2Cþ/BrdUþ proliferating myocytes from C, D. (C′, C
″, C‴) High-magniﬁcation images of the squared image in panel C showing Mef2Cþ/BrdUþ colocalization (C’), red ﬂuorescent channel for Mef2C (C″) and green ﬂuorescent
channel for BrdU (C‴). (D′, D″, D‴) High-magniﬁcation images of the squared image in panel D showing Mef2Cþ/BrdUþ colocalization (D′), red ﬂuorescent channel for Mef2C
(D″) and green ﬂuorescent channel for BrdU (D‴). *Po0.05; scale bars for A–D, 100 μm.
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siRNA knockdownwas capable of interfering with the RA signaling
that is normally required for heart regeneration, as demonstrated
by the reduction of both Mef2C/BrdU-positive and Gata4-GFP-
positive cardiomyocytes. This functional interference on cardio-
myocyte proliferation indices with RA signaling is a little less po-
tent than that induced by transgenic overexpression of dominant-
negative RA receptors or RA-degrading enzymes in adult zebraﬁsh
heart (Kikuchi et al., 2011). Therefore, this work presents a simple,
efﬁcient siRNA-delivery and gene-knockdown method, which will
be invaluable for loss-of-function analyses in the heart inparticular and likely for other organs of adult zebraﬁsh. This
method provides an alternative, important tool for functional
studies of genes in adult organs of vertebrate animals such as
zebraﬁsh, in which conditional-knockout methods are not
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